UnitedHealth Group (UNH - Free Report) reported $92.9 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 15.7%. EPS of $6.14 for the same period compares to $5.57 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $90.6 billion, representing a surprise of +2.54%. The company delivered an EPS surprise of +3.72%, with the consensus EPS estimate being $5.92.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Operating Statistics - Medical Care Ratio: 83.2% versus the eight-analyst average estimate of 82.8%.
- Customers - UnitedHealthcare - Total Commercial: 27175 thousand versus the six-analyst average estimate of 27377.93 thousand.
- Customers - UnitedHealthcare - Commercial- Risk-based: 8035 thousand versus the six-analyst average estimate of 8066.04 thousand.
- Customers - UnitedHealthcare - Commercial- Fee-based: 19140 thousand versus 19311.89 thousand estimated by six analysts on average.
- Revenues- Premiums: $72.47 billion versus $71.43 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +13.4% change.
- Revenues- Services: $8.66 billion versus $8.26 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +30.4% change.
- Revenues- Products: $10.65 billion versus $10.41 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +12.2% change.
- Revenues- Investment and other income: $1.12 billion compared to the $638.67 million average estimate based on nine analysts. The reported number represents a change of +278% year over year.
- Revenues- Optum Insight: $4.67 billion versus $4.60 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +42.4% change.
- Revenues- Optum Health: $23.92 billion compared to the $23.50 billion average estimate based on seven analysts. The reported number represents a change of +36% year over year.
- Revenues- UnitedHealthcare: $70.23 billion versus $69.07 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.
- Revenues- Optum Rx: $28.65 billion compared to the $27.11 billion average estimate based on seven analysts. The reported number represents a change of +15.5% year over year.
View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned -3.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
UnitedHealth Group (UNH - Free Report) reported $92.9 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 15.7%. EPS of $6.14 for the same period compares to $5.57 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $90.6 billion, representing a surprise of +2.54%. The company delivered an EPS surprise of +3.72%, with the consensus EPS estimate being $5.92.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Operating Statistics - Medical Care Ratio: 83.2% versus the eight-analyst average estimate of 82.8%.
- Customers - UnitedHealthcare - Total Commercial: 27175 thousand versus the six-analyst average estimate of 27377.93 thousand.
- Customers - UnitedHealthcare - Commercial- Risk-based: 8035 thousand versus the six-analyst average estimate of 8066.04 thousand.
- Customers - UnitedHealthcare - Commercial- Fee-based: 19140 thousand versus 19311.89 thousand estimated by six analysts on average.
- Revenues- Premiums: $72.47 billion versus $71.43 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +13.4% change.
- Revenues- Services: $8.66 billion versus $8.26 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +30.4% change.
- Revenues- Products: $10.65 billion versus $10.41 billion estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +12.2% change.
- Revenues- Investment and other income: $1.12 billion compared to the $638.67 million average estimate based on nine analysts. The reported number represents a change of +278% year over year.
- Revenues- Optum Insight: $4.67 billion versus $4.60 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +42.4% change.
- Revenues- Optum Health: $23.92 billion compared to the $23.50 billion average estimate based on seven analysts. The reported number represents a change of +36% year over year.
- Revenues- UnitedHealthcare: $70.23 billion versus $69.07 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +13.1% change.
- Revenues- Optum Rx: $28.65 billion compared to the $27.11 billion average estimate based on seven analysts. The reported number represents a change of +15.5% year over year.
View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned -3.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
Get the latest research report on UNH - FREE